Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clinical Trial of Microplasmin in Patients with Long-Term Venous Access Catheter Thrombosis
2005-003224-19Phase 2Completed
- Sponsor
- UZ Leuven
- Start
- Oct 2005
- Modality
- Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, single-arm trial of ocriplasmin in Thrombotic occlusion of central venous access device, sponsored by UZ Leuven. Primary endpoint: Safety and efficacy of catheter-directed microplasmin. Started Oct 2005; status: completed.
02
Drugs
ocriplasmin
03
Conditions
Thrombotic occlusion of central venous access device
Beyond the preview
Go deeper on 2005-003224-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-003224-19.